8-K: 3D Systems Q1 Revenue Up 1% Y/Y, EBITDA Turns Positive

3D Systems Corporation reported a 1% year-over-year revenue increase to $95.5 million for Q1 2026, with Adjusted EBITDA turning positive at $2.1 million.

Summary

• Q1 2026 revenue was $95.5 million, a 1% increase year-over-year, or 11% excluding the impact of divestitures.
• GAAP EPS loss narrowed to $(0.03), and non-GAAP EPS loss was $(0.01).
• Adjusted EBITDA improved to $2.1 million, reflecting higher sales volumes and continued cost reduction initiatives.
• Healthcare Solutions revenue increased approximately 21% to $50.1 million, driven by strong performance in Dental and Med Tech.
• Industrial Solutions revenue decreased approximately 15% to $45.4 million, but increased 2% year-over-year when adjusting for divestitures.
• Gross profit margin increased to 35.9% (GAAP) and 36.1% (non-GAAP).
• Net loss attributable to 3D Systems Corporation decreased by $32.6 million to $4.4 million.
• The company had total cash of $86.5 million at March 31, 2026.
• Second Quarter 2026 outlook projects revenue between $93 million and $95 million, and Adjusted EBITDA between ($4) million and ($2) million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, demonstrating a strong operational turnaround with positive Adjusted EBITDA and significant narrowing of net loss, driven by robust growth in key strategic segments. The Q2 outlook, while still showing negative Adjusted EBITDA, is a step towards full-year break-even.

Positives

• Revenue increased 1% year-over-year to $95.5 million, or 11% excluding divestitures, demonstrating a return of core revenue growth.
• GAAP EPS loss narrowed significantly to $(0.03) from $(0.28) in the prior year period.
• Adjusted EBITDA turned positive at $2.1 million, a substantial $25.9 million improvement compared to $(23.9) million in Q1 2025.
• Healthcare Solutions revenue grew robustly by approximately 21% to $50.1 million, now rivaling the Industrial segment's scale.
• Strong growth rates of more than 20% were achieved in Dental (excluding aligners), Med Tech, and Aerospace & Defense markets.
• Gross profit margin improved to 35.9% (GAAP) and 36.1% (non-GAAP), with non-GAAP gross profit margin increasing by 600 basis points adjusting for software divestitures.
• Net loss decreased substantially by $32.6 million to $4.4 million, primarily due to lower operating expenses, higher sales volume, and favorable revenue mix.
• Early success of recently launched products in Dental (monolithic dentures) and Aerospace & Defense (high-performance metal components) is expected to support sustained long-term revenue growth.

Negatives

• Industrial Solutions revenue decreased approximately 15% to $45.4 million, although it increased 2% year-over-year when adjusting for divestitures.
• The company still reported a GAAP net loss of $4.4 million and a diluted loss per share of $(0.03).
• Total cash decreased from $95.6 million at December 31, 2025, to $86.5 million at March 31, 2026.
• The Second Quarter 2026 Adjusted EBITDA outlook remains negative, ranging from ($4) million to ($2) million.

Risks

• The global economic environment remains uncertain, which could impact capital investment activity and demand for the company's products.
• Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from historical results or future projections.
• Factors described under the headings 'Forward-Looking Statements' and 'Risk Factors' in the company's periodic filings with the SEC could cause actual results to differ materially from those reflected or predicted.
• The company is unable to provide a quantitative reconciliation of forward-looking Adjusted EBITDA to GAAP measures without unreasonable effort due to the difficulty in predicting and estimating certain items like litigation expenses, acquisition expenses, stock-based compensation, intangible amortization, restructuring expenses, and goodwill impairment.

Future Outlook

The company anticipates building top-line momentum in key markets over the coming quarters, while maintaining disciplined cost management to achieve its goal of full-year break-even Adjusted EBITDA. It expects Q2 2026 revenue to be between $93 million and $95 million and Adjusted EBITDA to be between ($4) million and ($2) million. Management is optimistic about benefiting from an expansion in global manufacturing capacity as capital investment activity strengthens, driven by sustained investments in research and development and a broad pipeline of new products.

Management Comments

• "We are pleased with our first-quarter performance on both the top and bottom line, which exceeded our initial expectations." Dr. Jeffrey Graves, President and Chief Executive Officer.
• "Revenue growth was driven by strength in our key markets, including Dental, Med Tech, and Aerospace & Defense. These customers continue to rapidly adopt 3D printing as a core manufacturing technology and expand the range of applications they deploy." Dr. Jeffrey Graves.
• "As the additive manufacturing industry begins to emerge from a multiyear downturn, our sustained investments in research and development are enabling us to introduce a broad pipeline of new products that are gaining increasing customer traction." Dr. Jeffrey Graves.
• "Adjusting for divestitures completed in 2025, total revenue increased 11% year over year, demonstrating a return of core revenue growth as we move into 2026." Phyllis Nordstrom, Chief Financial Officer.
• "Strong sales across key product areas, along with a focus on margin expansion, profitability, and efficient cost management, positively contributed to our performance in the quarter. We remain committed to managing costs while making targeted investments in our priority markets to drive profitable growth." Phyllis Nordstrom.

Industry Context

StockSavvy.ai notes that 3D Systems' strong performance in Healthcare, particularly Dental and Med Tech, aligns with broader industry trends of increasing adoption of additive manufacturing for specialized, high-value applications. The company's focus on Aerospace & Defense also reflects a growing demand for advanced manufacturing in critical sectors. The CEO's comment about the additive manufacturing industry emerging from a multiyear downturn suggests a potential inflection point for the sector, where companies with diversified portfolios and R&D investments, like 3D Systems, are poised to capitalize on renewed capital investment.

Comparison to Industry Standards

• The 21% growth in Healthcare Solutions revenue, particularly the 20%+ growth in Dental and Med Tech, significantly outperforms the general industrial manufacturing sector, which has seen slower growth or contraction in recent periods.
• The positive Adjusted EBITDA of $2.1 million, a $25.9 million improvement, indicates a strong turnaround in operational efficiency compared to many smaller or less diversified additive manufacturing companies that may still be struggling with profitability.
• The company's broad additive manufacturing portfolio, covering direct metal printing and five major polymer technologies, positions it competitively against specialized players like Desktop Metal (metal 3D printing) or Carbon (polymer 3D printing), offering a more comprehensive solution set.
• The successful launch of new products for monolithic dentures and high-performance metal components demonstrates innovation comparable to industry leaders like Stratasys or EOS, who also continuously release new systems and materials to capture market share.

Stakeholder Impact

• Shareholders: Positive financial results, especially the return to positive Adjusted EBITDA and narrowed losses, could lead to increased investor confidence and potential share price appreciation. The company's strategic focus on high-growth markets like Healthcare and Aerospace & Defense suggests long-term value creation.
• Employees: Continued focus on cost management and strategic investments could lead to a more stable and growth-oriented work environment, though specific impacts on headcount are not detailed.
• Customers: Early success of new product launches indicates improved offerings and innovation, potentially enhancing customer satisfaction and market penetration in Dental, Med Tech, and Aerospace & Defense.
• Creditors: The company's improved financial performance and positive Adjusted EBITDA strengthen its ability to meet debt obligations, with only $3.9 million maturing in Q4 2026 and the majority in 2030.

Next Steps

• Continue building top-line momentum in key markets over the coming quarters.
• Maintain disciplined cost management to achieve the goal of full-year break-even Adjusted EBITDA.
• Host a conference call and webcast on May 12, 2026, at 8:30 a.m. Eastern Time to discuss these results.

Key Dates

Recommendation

The company has demonstrated a significant operational turnaround, exceeding expectations with positive Adjusted EBITDA and substantial narrowing of net losses. Core revenue growth, excluding divestitures, is strong at 11%, driven by high-growth segments like Healthcare (21% growth). While the Q2 outlook is cautious, the overall trajectory suggests a company emerging from a downturn with disciplined cost management and strategic investments in promising markets. This indicates a strong potential for future profitability and market share gains, making it an attractive investment.

Keywords

3D Systems, DDD, Q1 2026 Earnings, Additive Manufacturing, 3D Printing, Healthcare Solutions, Industrial Solutions, Financial Results, Adjusted EBITDA, Revenue Growth, Dental, Med Tech, Aerospace & Defense